Free Trial

Cue Biopharma (CUE) Insider Trading & Ownership

→ These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad)
Free CUE Stock Alerts
$1.41
-0.01 (-0.70%)
(As of 04/25/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Cue Biopharma (NASDAQ:CUE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.24%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$19,620.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get CUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cue Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CUE Insider Buying and Selling by Quarter

Ad Colonial Metals
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.

Cue Biopharma Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2023Anish SuriInsiderBuy4,000$2.76$11,040.00  
8/14/2023Daniel R PasseriCEOBuy3,000$2.86$8,580.00  
(Data available from 1/1/2013 forward)

CUE Insider Trading Activity - Frequently Asked Questions

Who is on Cue Biopharma's Insider Roster?

The list of insiders at Cue Biopharma includes Aaron G.L. Fletcher, Anish Suri, Daniel R Passeri, Kerri-Ann Millar, and Peter A Kiener. Learn more on insiders at CUE.

What percentage of Cue Biopharma stock is owned by insiders?

10.24% of Cue Biopharma stock is owned by insiders. Learn more on CUE's insider holdings.

Which Cue Biopharma insiders have been buying company stock?

The following insiders have purchased CUE shares in the last 24 months: Aaron G.L. Fletcher ($528,000.00), Anish Suri ($11,040.00), and Daniel R Passeri ($8,580.00).

How much insider buying is happening at Cue Biopharma?

Insiders have purchased a total of 157,000 CUE shares in the last 24 months for a total of $547,620.00 bought.

Which Cue Biopharma insiders have been selling company stock?

The following insider sold CUE shares in the last 24 months: Peter A Kiener ($30,586.00).

How much insider selling is happening at Cue Biopharma?

Insiders have sold a total of 9,325 Cue Biopharma shares in the last 24 months for a total of $30,586.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:CUE) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Fed launches fourth dollar overhaul
Stansberry Research
The only accurate crypto trading system I know …
Weiss Ratings
Better than Bitcoin? The Biotech Stock with 46,751% Potential
Behind the Markets